LCD L33826: Oral Anticancer Drugs — DME MAC
Policy LCD-L33826 · Oncology
DME MAC LCD for oral anticancer drugs effective Jan 1, 2026.
Code intelligence
J8530 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code J8530.
Normal code riskView HCPCS detail
Signal breakdown
1 shown · 1 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
1
Routine
100%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
Audit documentation
Building an audit file that includes J8530?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription